- Impact of rs12917 MGMT Polymorphism on [F-18]FDG-PET Response in Pediatric Hodgkin Lymphoma (PHL)2019 | 2. lékařská fakulta
- Differentiation between rebound thymic hyperplasia and thymic relapse after chemotherapy in pediatric Hodgkin lymphoma2023 | 2. lékařská fakulta
- Optimized Whole-Body PET MRI Sequence Workflow in Pediatric Hodgkin Lymphoma Patients2023 | Publikace bez příslušnosti k fakultě
- Pulmonary lesions in early response assessment in pediatric Hodgkin lymphoma: prevalence and possible implications for initial staging2024 | 2. lékařská fakulta
- Risk and Response Adapted Treatment Guidelines for Managing First Relapsed and Refractory Classical Hodgkin Lymphoma in Children and Young People. Recommendations from the EuroNet Pediatric Hodgkin Lymphoma Group2020 | 2. lékařská fakulta
- F-18-FDG PET Response of Skeletal (Bone Marrow and Bone) Involvement After Induction Chemotherapy in Pediatric Hodgkin Lymphoma: Are Specific Response Criteria Required?2018 | 2. lékařská fakulta
- Assessment of Waldeyer's ring in pediatric and adolescent Hodgkin lymphoma patients-Importance of multimodality imaging: Results from the EuroNet-PHL-C1 trial2021 | 2. lékařská fakulta
- qPET - a quantitative extension of the Deauville scale to assess response in interim FDG-PET scans in lymphoma2014 | 2. lékařská fakulta